Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Subcutaneous administration of ADAMTS13

Subcutaneous administration of ADAMTS13

US Patent 11185575 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII vari2024
Anti-factor IX padua antibodies2024
Subcutaneous administration of ADAMTS132023
Subcutaneous administration of ADAMTS132023
Subcutaneous administration of ADAMTS132023
Subcutaneous administration of ADAMTS132023
Viral vectors encoding recombinant FVIII variants with increased expression for 2023
Gene therapy of hemophilia B using viral vectors encoding recombinant fix varian2023
Nucleophilic catalysts for oxime linkage2023
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
ADAMTS13-containing compositions having thrombolytic activity2021